On 2026-11-10, Eupraxia Pharmaceuticals Inc. (T.EPR) announced earnings per share of -0.32 for the fiscal quarter ending 2026-09-30, beating the average analyst estimate of -0.36.
The next expected annoucement date for quarterly earnings is 2027-03-11, with an average estimated earnings per share of -0.38 for the fiscal quarter ending 2026-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-11-10 | 2026-09-30 | -0.36 | -0.32 |
| 2026-08-11 | 2026-06-30 | -0.35 | -0.32 |
| 2026-05-12 | 2026-03-31 | -- | -0.32 |
| 2026-03-12 | 2025-12-31 | -- | -0.52 |
| 2025-11-04 | 2025-09-30 | -- | -0.26 |
| 2025-08-12 | 2025-06-30 | -- | -0.36 |
| 2025-05-06 | 2025-03-31 | -- | -0.30 |